Back

Gene therapy to avoid development of cardiomyopathy

14 April 2023 (12:09 - 12:21)
Organised by:
Congress Presentation Part of: How genes and the environment interact to shape individual CV risk Biomarkers EAPC Premium Access ESC Preventive Cardiology 2023

About the speaker

Photo
Doctor Francesca Stillitano

University Medical Center Utrecht, Utrecht (Netherlands (The))

4 More presentations in this session

Presentation thumbnail
Polygenic risk scores for preventing cardiometabolic disease: are we there yet?
Professor M. Kavousi (Rotterdam, NL)
Slides Video
Presentation thumbnail
Young sudden cardiac death: an interplay of genetic, lifestyle and environmental factors
Doctor P. Chockalingam (Chennai, IN)
Slides Video
Presentation thumbnail
Are athletes made or born?: gene/environmental interaction may provide the answer
Professor A. La Gerche (Melbourne, AU)
Slides Video
Presentation thumbnail
Discussion – How genes and the environment interact to shape individual CV risk
Video

Access the full session

Session thumbnail
How genes and the environment interact to shape individual CV risk
Video

The Event

Event poster

ESC Preventive Cardiology 2023

14 April 2023 12:09 CET
You may be interested in
thumbnail
Congress Presentation
Gene editing to correct monogenic cardiomyopathies
31 August 2024
thumbnail
Congress Presentation
Knockdown of phospholamban using antisense oligonucleotides halts disease progression and resolves protein aggregation in mice with advanced phospholamban p.Arg14del cardiomyopathy
22 May 2022
thumbnail
Congress Presentation
Gene therapies for inherited arrythmias
26 August 2023
thumbnail
Congress Presentation
Gene editing for Danon disease
31 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources